MedPath

Dose response study of phytosterols in tablet dosage in adults with primary hypercholeterolemia

Phase 2
Completed
Conditions
Primary hypercholesterolemia
Diet and Nutrition - Other diet and nutrition disorders
Registration Number
ACTRN12605000303640
Lead Sponsor
Mayne Health Consumer Products
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
80
Inclusion Criteria

1) LDL cholesterol greater then or equal to 3.5mmol/L and less than or equal to 5.7 mmol/L 2) Body mass index less than or equal to 32kg/m2

Exclusion Criteria

1) Triglyceride levels greater then 4mmol/L2) Total cholesterol greater than 10mmol/L3) Use of lipid lowering medications including herbal and other natural lipid lowering agents with one month of baseline4) Clinically abnormal liver function tests at baseline5) Pregnant or women unwilling to use birth control for the period of the study6) Diabetes7) Hypothyroidism8) Smokers9) Cardiovascular disease10) Subjects unwilling to comply with study protocol11) Poor venous access12) Any other condition which in the opinion of the investigators could compromise the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in LDL cholesterol from baseline to end of treatment.[At baseline and at end of treatment]
Secondary Outcome Measures
NameTimeMethod
Changes in total cholesterol[Following 12 weeks of treatment.];Changes in high density lipoprotein cholesterol and triglycerides[Following 12 weeks of treatment.]
© Copyright 2025. All Rights Reserved by MedPath